Related Articles
Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer
Clinical significance of LGR5 and CD44 expression in locally advanced rectal cancer after preoperative chemoradiotherapy
Immunohistochemical features of CD133 expression: Association with resistance to chemoradiotherapy in rectal cancer
Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy
Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy